Cohance Lifesciences has announced the appointment of Gunjan Singh as Chief Executive Officer – API Plus Business. In this strategic leadership role, he will drive the company’s API Plus vertical, focusing on global business expansion, portfolio growth, and operational excellence. His appointment underscores Cohance’s vision to strengthen its integrated API and formulation strategy, positioning the company as a diversified, innovation-led pharmaceutical leader.

With over two decades of experience in the pharmaceutical and consulting sectors, Gunjan has successfully led global operations and business transformations. Previously, he served as Business Head – API and Formulations at Cohance Lifesciences. His career includes senior roles at Dr. Reddy’s Laboratories, Wanbury Limited, Jubilant Pharma, and Piramal Enterprises, where he earned the prestigious Chairman’s Award. Earlier, he worked with Accenture, EY, and Larsen & Toubro, bringing deep expertise in strategy, finance, and operations.

CXO TechBOT congratulates Gunjan Singh on this significant leadership milestone.